| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:141-148.)
© 2004 American Heart Association, Inc.
Original Articles |
-Tocopherol
From the Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan (T.M., M.A.); The Cardiovascular Research Institute, Kurume University, Kurume, Japan (H.I., N.H., A.K., Y.T., T.I.); and the Department of Cardiology, National Cardiovascular Center, Suita, Japan (Y.O.).
Correspondence to Dr Toyoaki Murohara, Department of Cardiology, Nagoya University Graduate School of Medicine, 65 Tsurumai, Showa-ku, Nagoya 466-8550, Japan. E-mail murohara{at}med.nagoya-u.ac.jp
Received May 9, 2001; de novo received December 27, 2003; revision received March 23, 2004; accepted March 24, 2004.
Background Platelet-leukocyte interaction is an early important event for thrombogenesis, and this process is mainly mediated by P-selectin on platelets. Although
-tocopherol has been shown to inhibit thrombotic disorders, the effect of
-tocopherol on platelet P-selectin expression and platelet-leukocyte interaction is little known.
Methods and Results We examined whether
-tocopherol inhibited human platelet P-selectin expression and platelet-leukocyte interaction.
-Tocopherol (50 to 500 µg/mL) inhibited thrombin-induced or phorbol 12-myristate 13-acetate (PMA)-induced P-selectin expression on platelets.
-Tocopherol suppressed plateletmononuclear cell (MNC) interaction, platelet aggregation, and platelet protein kinase C (PKC) activity stimulated with either PMA (100 nmol/L) or thrombin. Inhibitory actions of
-tocopherol against the platelet functions were mimicked by staurosporine, a selective PKC inhibitor. After oral supplementation of
-tocopherol (300 mg/d for 3 weeks) in healthy subjects, thrombin-mediated or PMA-mediated P-selectin expression, platelet-MNC interaction, and platelet aggregation ex vivo were suppressed.
Conclusions
-Tocopherol inhibited P-selectin expression on human platelets and thereby attenuated platelet-MNC interactions, which were mediated at least in part by the inhibition of intraplatelet PKC activity. These actions of
-tocopherol on platelet functions provide new insights into the antithromboatherogenic properties of
-tocopherol.
Key Words: thrombus platelets leukocytes antioxidants hemorrhage
This article has been cited by other articles:
![]() |
R. J. Glynn, P. M Ridker, S. Z. Goldhaber, R. Y.L. Zee, and J. E. Buring Effects of Random Allocation to Vitamin E Supplementation on the Occurrence of Venous Thromboembolism: Report From the Women's Health Study Circulation, September 25, 2007; 116(13): 1497 - 1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W Clarke, N. C Ward, J. H. Wu, J. M Hodgson, I. B Puddey, and K. D Croft Supplementation with mixed tocopherols increases serum and blood cell {gamma}-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes Am. J. Clinical Nutrition, January 1, 2006; 83(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |